Genenta Science Statistics
Total Valuation
Genenta Science has a market cap or net worth of $72.43 million. The enterprise value is $54.34 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Genenta Science has 18.29 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 18.29M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 28.25% |
| Owned by Institutions (%) | 6.85% |
| Float | 11.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.02 |
| P/TBV Ratio | 4.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.30 |
| Quick Ratio | 9.07 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.89% and return on invested capital (ROIC) is -28.35%.
| Return on Equity (ROE) | -42.89% |
| Return on Assets (ROA) | -25.83% |
| Return on Invested Capital (ROIC) | -28.35% |
| Return on Capital Employed (ROCE) | -55.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$683,040 |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.76% in the last 52 weeks. The beta is 0.74, so Genenta Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -11.76% |
| 50-Day Moving Average | 4.40 |
| 200-Day Moving Average | 4.23 |
| Relative Strength Index (RSI) | 47.29 |
| Average Volume (20 Days) | 5,410 |
Short Selling Information
| Short Interest | 3,377 |
| Short Previous Month | 2,577 |
| Short % of Shares Out | 0.03% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.13M |
| Pretax Income | -12.73M |
| Net Income | -9.56M |
| EBITDA | -10.08M |
| EBIT | -10.13M |
| Earnings Per Share (EPS) | -$0.52 |
Full Income StatementBalance Sheet
The company has $18.11 million in cash and $22,505 in debt, giving a net cash position of $18.09 million or $0.99 per share.
| Cash & Cash Equivalents | 18.11M |
| Total Debt | 22,505 |
| Net Cash | 18.09M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 18.02M |
| Book Value Per Share | 0.99 |
| Working Capital | 17.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.09 million and capital expenditures -$3,453, giving a free cash flow of -$5.95 million.
| Operating Cash Flow | -6.09M |
| Capital Expenditures | -3,453 |
| Free Cash Flow | -5.95M |
| FCF Per Share | -$0.33 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |